Immune-related adverse events after a single dose of pembrolizumab. Vos H, Lambein K, Wildiers H, Punie K, et al. Eur J Cancer 2021;148:92-94.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vos H, Lambein K, Wildiers H, Punie K, et al. Immune-related adverse events after a single dose of pembrolizumab. Eur J Cancer 2021;148:92-94.
PMID: 33740501